Medical Imaging Centers of America earlier this month lost a roundin its battle to prevent a group of shareholders from taking overthe San Diego company (SCAN 1/17/95). A U.S. District Court magistraterejected MICA's request for expedited discovery in
Medical Imaging Centers of America earlier this month lost a roundin its battle to prevent a group of shareholders from taking overthe San Diego company (SCAN 1/17/95). A U.S. District Court magistraterejected MICA's request for expedited discovery in its lawsuitagainst Steel Partners II of New York City. The ruling preventsMICA from serving Steel Partners with requests for discovery untila judge hears the group's motion to dismiss MICA's lawsuit, accordingto Daniel Burch, a Steel Partners spokesperson.
The ruling was related only to discovery and does not affectthe merits of MICA's lawsuit against Steel Partners, accordingto MICA. The company's request for an injunction barring SteelPartners' takeover effort will take place Feb. 20, six days beforea shareholder meeting that Steel Partners has called to removeMICA's board. A motion by Steel Partners to dismiss MICA's lawsuitwill also take place Feb. 20.
One member of MICA's board stepped down this month in a moverelated to the takeover battle. The member, Keene Wolcott, saidhe did not agree with MICA's decision to sue Steel Partners orthe company's poison pill defense.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.